18 Amlodipine Tablet Producing, Medicine GMP

• Customization: Available
• Application: Antipyretic and Anti-Inflammatory
• State: Solid
• Model NO.: 10 tablets /blister
• Shape: Tablet
• Type: Inorganic Chemicals
• Pharmaceutical Technology: Chemical Synthesis
• Drug Reg./Approval No.: 300490
• Drug Ad Approval No.: 300490
• COA: Available
• Test Repot: Available
• Register Dossier: Available
• Period of Validity: 3 Years
• Transport Package: Blister
• Specification: 10tablets/box
• Trademark: UK
• Origin: UK
• HS Code: 2804100000
• Production Capacity: 5000000000000000000000PC/Year

Product Description

18 amlodipine tablet producing,medicine GMP
Amlodipine, a calcium antagonist, is used in the treatment of all types of hypertension (alone or in combination with other drugs) and angina pectoris, especially spontaneous angina (alone or in combination with other drugs). The product has a protective effect on the kidneys. Its preparations include amlodipine benzenesulfonate tablets, amlodipine mesylate tablets, and levamlodipine maleate tablets.
indications:
1. Primary hypertension. Apply alone or in combination with other anti-hypertensive drugs.

2. Chronic stable angina and variant angina. Applied alone or in combination with other anti-hypertensive drugs.

3. Coronary artery disease confirmed by angiography.
Usage and dosage:
Oral, the starting dose of 5mg once a day, and then gradually increased to 10mg per day as needed, the elderly and people with reduced renal function or the combined application of other antihypertensive drugs or anti-anginal drugs do not need to adjust the dose. However, the initial dose should be 2.5mg once daily; this dose can also be used as a therapeutic dose when other antihypertensive drugs are used.

The dose should be adjusted according to the individual response, and the general dose adjustment should be carried out in 7~14 days. If clinically necessary, dose adjustments may be initiated within a short period of time after close patient testing.